Rohto Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: FMCG
  • ISIN: JP3982400008
JPY
2,862.50
500 (21.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Pola Orbis Holdings, Inc.
Rohto Pharmaceutical Co., Ltd.
Shiseido Co., Ltd.
Milbon Co., Ltd.
Noevir Holdings Co., Ltd.
Kao Corp.
Pigeon Corp.
Lion Corp.
Unicharm Corp.
FANCL Corp.
KOSÉ Corp.

Why is Rohto Pharmaceutical Co., Ltd. ?

1
Flat results in Jun 26
  • ROCE(HY) Lowest at 11.5%
2
With ROE of 12.72%, it has a attractive valuation with a 1.90 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 15.94%, its profits have risen by 21.6% ; the PEG ratio of the company is 0.7
  • At the current price, the company has a high dividend yield of 0
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 15.94% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 59.79%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Rohto Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to FMCG should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Rohto Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Rohto Pharmaceutical Co., Ltd.
15.94%
-0.11
33.30%
Japan Nikkei 225
60.14%
2.04
29.37%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
13.28%
EBIT Growth (5y)
12.88%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.99
Tax Ratio
26.49%
Dividend Payout Ratio
30.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.11%
ROE (avg)
12.73%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.90
EV to EBIT
13.14
EV to EBITDA
9.15
EV to Capital Employed
1.97
EV to Sales
1.56
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
15.00%
ROE (Latest)
12.72%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET SALES(Q)

Highest at JPY 91,624 MM

RAW MATERIAL COST(Y)

Fallen by -0.72% (YoY

CASH AND EQV(HY)

Highest at JPY 171,587 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 2.4 times

DEBTORS TURNOVER RATIO(HY)

Highest at 5.14 times

-2What is not working for the Company
ROCE(HY)

Lowest at 11.5%

Here's what is working for Rohto Pharmaceutical Co., Ltd.

Net Sales
Highest at JPY 91,624 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (JPY MM)

Cash and Eqv
Highest at JPY 171,587 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Inventory Turnover Ratio
Highest at 2.4 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 5.14 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -0.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales